Wide Ranks

IMNN

Imunon, Inc.

0.8560

Top Statistics
Market Cap 12 M Forward PE -0.7045 Revenue Growth 0.00 %
Current Ratio 2.30 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.1630 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 10 M Total Cash Per Share 0.7110 Total Debt 1 M
Total Debt To Equity 15.46 Current Ratio 2.30 Book Value Per Share 0.5650
All Measures
Short Ratio 342.00 % Message Board Id finmb_260398 Fax 609 896 2200
Shares Short Prior Month 337569 Return On Equity -1.48 City Lawrenceville
Uuid 8c345872-fb05-3c41-be37-d6105d702b42 Previous Close 0.8289 First Trade Date Epoch Utc 920 M
Book Value 0.5650 Beta 2.13 Total Debt 1 M
Volume 134829 Price To Book 1.52 Last Split Date 1 B
Fifty Two Week Low 0.4800 Total Cash Per Share 0.7110 Shares Short Previous Month Date 1 B
Target Median Price 12.00 Max Age 86400 Recommendation Mean 1.25
Sand P52 Week Change 0.3133 Target Mean Price 13.20 Net Income To Common -19451150
Short Percent Of Float 0.0485 Implied Shares Outstanding 14 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 206970 Average Volume10days 206970
Total Cash 10 M Next Fiscal Year End 1 B Held Percent Insiders 0.0109
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 0.8289 Target Low Price 5.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 0.9286 Open 0.8350 Free Cashflow -11627516
State NJ Dividend Yield 0.00 % Return On Assets -0.6708
Time Zone Short Name EST Trailing Eps -1.91 Day Low 0.8250
Address1 997 Lenox Drive Shares Outstanding 14 M Price Hint 4
Target High Price 29.00 Website https://imunon.com 52 Week Change -0.0444
Average Volume 217081 Forward Eps -1.09 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 189.50 % Last Split Factor 1:15
Regular Market Day High 0.8700 Is_sp_500 False Profit Margins 0.00 %
Debt To Equity 15.46 Fifty Two Week High 3.65 Day High 0.8700
Shares Short 702037 Regular Market Open 0.8350 Industry Key biotechnology
Earnings Growth 0.00 % Revenue Growth 0.00 % Shares Percent Shares Out 0.0484
Operating Cashflow -18206252 Currency USD Time Zone Full Name America/New_York
Market Cap 12 M Is_nasdaq_100 False Zip 08648
Quote Type EQUITY Industry Biotechnology Long Name Imunon, Inc.
Regular Market Day Low 0.8250 Held Percent Institutions 0.0703 Current Price 0.8560
Address2 Suite 100 Enterprise To Ebitda -0.1630 Financial Currency USD
Current Ratio 2.30 Industry Disp Biotechnology Number Of Analyst Opinions 5
Country United States Float Shares 13 M Two Hundred Day Average 1.14
Enterprise Value 3 M Forward PE -0.7045 Regular Market Volume 134829
Ebitda -20679308 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases.

The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development.

Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma.

In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon's DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase for the development of personalized cancer vaccines or neoepitope cancer vaccines.

Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022.

The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.